The initiative was introduced at the Health-RI conference in Amersfoort, Netherlands to an audience of researchers, academics and clinicians.
The growth of Aridhia’s operations outside the UK follows the partnership agreement with Vancis announced in mid-2015. A number of new jobs in both Scotland and the Netherlands are expected to be created as a result of this collaboration.
Based on Aridhia’s AnalytiXagility data analysis platform, RSRCH-Health was first established in early 2016 to deliver a digital research environment to Radboudumc Nijmegen in a three-year deal, making it the first University Medical Centre in the Netherlands to offer a digital platform to all research teams across the institution.
Radboudumc is currently rolling out RSRCH-Health across the entire organisation, providing analytical workspaces for up to 1600 research projects to accelerate the delivery of research studies into clinical practice.
The extended Vancis, Aridhia, and MGRID collaboration - which goes by the name RSRCH - signifies continued growth for Aridhia, one of Scotland’s data science success stories.
Chris Roche, Aridhia’s CEO, said of the new company: "The development of AnalytiXagility into a tailored offering for the Netherlands’ market is very exciting for Aridhia and is validation that our platform is precisely what research-driven organisations need to achieve the best outcomes.
"Research teams worldwide are realising the value in wide-scale collaboration around data, and together with Vancis and MGRID, we believe that RSRCH-Health represents an answer to the data challenges that they face."
Developed to deliver rapid change by enabling a multidisciplinary, collaborative approach to biomedical research, RSRCH-Health is available via the Amsterdam based RSRCH team and is suitable for individual studies, or as the digital environment for all projects within a research-driven institution.
This partnership adds to Aridhia’s growing portfolio of European projects as it exports AnalytiXagility to prominent research collaborations across the continent, including the ground-breaking European Prevention of Alzheimer’s Dementia (EPAD) project, an Innovative Medicines Initiative funded research programme.
Click below to sign up for daily business updates